Analysis of relapse rates in pegylated interferon and ribavirin non-responders treated with daily consensus interferon and ribavirin

被引：0
|
作者：
Hassanein, Tarek
Ghalib, Reem H.
Zein, Nizar N.
Rothstein, Kenneth D.
Joshi, Shobha N.
Kwo, Paul Yien
Hammond, Janet
机构：
[1] Univ Calif San Diego, Ctr Liver, San Diego, CA 92103 USA
[2] Methodist Hosp, Liver Inst, Dallas, TX USA
[3] Cleveland Clin, Cleveland, OH 44106 USA
[4] Albert Einstein Ctr Liver Dis, Philadelphia, PA USA
[5] Tulane Univ, New Orleans, LA 70118 USA
[6] Indiana Univ, Indianapolis, IN 46204 USA
[7] Valeant Pharmaceut N Amer, Aliso Viejo, CA USA
来源：
HEPATOLOGY | 2007年 / 46卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1319
引用
收藏
页码：824A / 824A
页数：1
相关论文
共 50 条
  • [21] Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin
    Maria H. Sjogren
    Robert Sjogren
    Michael F. Lyons
    Michael Ryan
    John Santoro
    Coleman Smith
    K. Rajender Reddy
    Herbert Bonkovsky
    Brooke Huntley
    Sima Faris-Young
    Digestive Diseases and Sciences, 2007, 52 : 1540 - 1547
  • [22] The Role of Autophagy in Interferon/Ribavirin Responders and Non-Responders with Hepatitis C Virus Infection
    Abbasi, Fahimeh
    Bamdad, Taravat
    Ghadimi-Moghadam, Abdolkarim
    Chubin, Hamzeh
    Jamalidoust, Marzieh
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2020, 13 (03)
  • [23] Combination therapy with interferon alfa-2b, ribavirin, and amantadine in chronic hepatitis C non-responders to interferon and ribavirin
    Pande, H
    Thuluvath, PJ
    Jaffer, SA
    Maygers, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2002, 97 (09): : S96 - S96
  • [24] Interferon-α plus ribavirin for the treatment of chronic hepatitis C in non-responders to interferon-α
    Tromm, A
    Greving, I
    Hueppe, D
    GASTROENTEROLOGY, 1999, 116 (04) : A834 - A834
  • [25] Interferon alpha with ribavirin for the treatment of chronic hepatitis C in non-responders or relapsers to interferon monotherapy
    Moreno-Monteagudo, JA
    Fernandez-Bermejo, M
    Garcia-Buey, L
    Sanz, P
    Iacono, LO
    Garcia-Monzon, C
    Borque, MJ
    Moreno-Otero, R
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 (08) : 717 - 723
  • [26] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Yee, Helen S.
    Currie, Sue L.
    Tortorice, Kathryn
    Cozen, Myrna
    Shen, Hui
    Chapman, Summer
    Cunningham, Fran
    Monto, Alexander
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2439 - 2448
  • [27] Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study
    Helen S. Yee
    Sue L. Currie
    Kathryn Tortorice
    Myrna Cozen
    Hui Shen
    Summer Chapman
    Fran Cunningham
    Alexander Monto
    Digestive Diseases and Sciences, 2011, 56 : 2439 - 2448
  • [28] High and daily dosing therapy with consensus interferon plus ribavirin for combination therapy non-responders with chronic hepatitis C.
    Kaiser, S
    Kreysel, C
    Hass, H
    Gregor, M
    HEPATOLOGY, 2001, 34 (04) : 582A - 582A
  • [29] Ribavirin followed by alpha interferon retreatment in relapsers and in non-responders to alpha interferon for chronic hepatitis C
    Bellobuono, A
    Mondazzi, L
    Tempini, S
    Bellati, G
    Ideo, G
    HEPATOLOGY, 1996, 23 (01) : P99 - P99
  • [30] Combination antiviral therapy with ribavirin and interferon alfa in interferon alfa relapsers and non-responders: Italian experience
    Brillanti, S
    Miglioli, M
    Barbara, L
    JOURNAL OF HEPATOLOGY, 1995, 23 : 13 - 16
12345